[Efficacy of erlotinib after the failure of gefitinib in patients with metastasis of non-small cell lung cancer with unknown EGFR mutation status].

Wang, Yan; Li, Jun-ling; Wang, Zi-ping; Hao, Xue-zhi; Wang, Bin; Zhang, Xiang-ru; Shi, Yuan-kai

Wang, Yan; Li, Jun-ling; Wang, Zi-ping; Hao, Xue-zhi; Wang, Bin; Zhang, Xiang-ru; Shi, Yuan-kai.

Affiliation

Wang Y; Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Zhonghua Zhong Liu Za Zhi ; 34(10): 780-4, 2012 Oct.

Article in Zh | MEDLINE | ID: mdl-23291074

Subject(s)

Carcinoma, Non-Small-Cell Lung/drug therapy; ErbB Receptors/genetics; Lung Neoplasms/drug therapy; Mutation; Quinazolines/therapeutic use; Adult; Aged; Antineoplastic Agents/therapeutic use; Carcinoma, Non-Small-Cell Lung/genetics; Carcinoma, Non-Small-Cell Lung/pathology; Disease-Free Survival; ErbB Receptors/antagonists & inhibitors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms/genetics; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Protein Kinase Inhibitors/therapeutic use; Remission Induction; Retrospective Studies; Survival Rate

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms / Mutation Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2012 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google